Literature DB >> 34300349

Review of Rhinitis: Classification, Types, Pathophysiology.

Georgia A Liva1, Alexander D Karatzanis1, Emmamuel P Prokopakis1.   

Abstract

Rhinitis describes a pattern of symptoms as a result of nasal inflammation and/or dysfunction of the nasal mucosa. It is an umbrella entity that includes many different subtypes, several of which escape of complete characterization. Rhinitis is considered as a pathologic condition with considerable morbidity and financial burden on health care systems worldwide. Its economic impact is further emphasized by the fact that it represents a risk factor for other conditions such as sinusitis, asthma, learning disabilities, behavioral changes, and psychological impairment. Rhinitis may be associated with many etiologic triggers such as infections, immediate-type allergic responses, inhaled irritants, medications, hormonal disturbances, and neural system dysfunction. It is basically classified into three major clinical phenotypes: allergic rhinitis (AR), infectious rhinitis, and non-allergic, non-infectious rhinitis (NAR). However, this subdivision may be considered as an oversimplification because a combined (mixed) phenotype exists in many individuals and different endotypes of rhinitis subgroups are overlapping. Due to the variety of pathophysiologic mechanisms (endotypes) and clinical symptoms (phenotypes), it is difficult to develop clear guidelines for diagnosis and treatment. This study aims to review the types of allergic and non-allergic rhinitis, providing a thorough analysis of the pathophysiological background, diagnostic approach, and main treatment options.

Entities:  

Keywords:  allergic; atrophic; gustatory; idiopathic; non-allergic; occupational; review; rhinitis

Year:  2021        PMID: 34300349     DOI: 10.3390/jcm10143183

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  6 in total

Review 1.  The gut microbiome and allergic rhinitis; refocusing on the role of probiotics as a treatment option.

Authors:  Jianghua Li; Fang Fang; Mei Mei; Dongmei Wu
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-10-14       Impact factor: 3.236

2.  Ameliorative Effect of a Neoteric Regimen of Catechin plus Cetirizine on Ovalbumin-Induced Allergic Rhinitis in Rats.

Authors:  Mohamed A Morsy; Snehal S Patel; Anita Bakrania; Mahmoud Kandeel; Anroop B Nair; Jigar N Shah; Sabah H Akrawi; Mahmoud El-Daly
Journal:  Life (Basel)       Date:  2022-05-31

3.  Plant-Derived Lactobacillus paracasei IJH-SONE68 Improves Chronic Allergy Status: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.

Authors:  Masafumi Noda; Keishi Kanno; Narandalai Danshiitsoodol; Fumiko Higashikawa; Masanori Sugiyama
Journal:  Nutrients       Date:  2021-11-11       Impact factor: 5.717

4.  Mometasone Furoate in Non-Allergic Rhinitis: A Real-Life Italian Study.

Authors:  Angela Rizzi; Giuseppe Parrinello; Eugenio De Corso; Laura Tricarico; Michele Centrone; Alessia Di Rienzo; Chiara Laface; Giulio Cesare Passali; Gabriella Cadoni; Riccardo Inchingolo; Gaetano Paludetti; Jacopo Galli; Eleonora Nucera
Journal:  J Pers Med       Date:  2022-07-20

5.  Cell division cycle 42 reflects disease risk, symptoms, Th1/Th2 disproportion, and its short-term variation indicates symptom amelioration after treatment in allergic rhinitis patients.

Authors:  Xiaote Zhang; Lujie Xie; Xiaoyun Fang
Journal:  J Clin Lab Anal       Date:  2022-08-31       Impact factor: 3.124

6.  Clinical study on the treatment of moderate to severe persistent allergic rhinitis by posterior nasal nerve combined with anterior ethmoid neurotomy.

Authors:  Rongrong Wu; Lvhua Dong; Huajie Mao; Jianjun Wang; Dijiang Ma; Jianing Sun
Journal:  Pak J Med Sci       Date:  2022 Sep-Oct       Impact factor: 2.340

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.